Medicare Enrolled
Dr. Lawrence Goldstein, MD
Critical Care Medicine · Boardman, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Goldstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goldstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Goldstein
Dr. Lawrence Goldstein is a critical care medicine specialist in Boardman, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Goldstein performed 1,280 Medicare services across 866 unique beneficiaries.
Between the years covered by Open Payments, Dr. Goldstein received a total of $10,991 from 51 pharmaceutical and/or device companies across 529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Goldstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in OH
$10,991 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,280
Medicare services
Top 14% in OH for critical care medicine
866
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~64 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
403 | $62 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
168 | $88 | $240 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
153 | $169 | $550 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
115 | $94 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
83 | $58 | $160 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
68 | $7 | $212 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
60 | $136 | $370 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
52 | $9 | $200 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
44 | $99 | $250 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
31 | $17 | $85 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
29 | $27 | $165 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $110 | $310 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
21 | $9 | $135 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
14 | $75 | $188 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
14 | $29 | $48 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,991
Total received (2018-2024)
Avg $1,570/year across 7 years
Top 12% in OH for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
529
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,795 (98.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$150 (1.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$46 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,317
2023
$2,377
2022
$1,463
2021
$638
2020
$1,083
2019
$1,354
2018
$1,760
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$742
GlaxoSmithKline, LLC.
$382
Regeneron Healthcare Solutions, Inc.
$205
Pulmonx Corporation
$130
Merck Sharp & Dohme LLC
$97
Electromed, Inc.
$93
Mylan Specialty L.P.
$66
Genentech USA, Inc.
$66
United Therapeutics Corporation
$58
Takeda Pharmaceuticals U.S.A., Inc.
$45
Amgen Inc.
$44
JAZZ PHARMACEUTICALS INC.
$41
Philips North America LLC
$41
Avadel CNS Pharmaceuticals, LLC
$40
Mallinckrodt Hospital Products Inc.
$37
GENZYME CORPORATION
$37
HARMONY BIOSCIENCES LLC
$36
Grifols USA, LLC
$24
CSL Behring
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Harmony Biosciences Llc
$17
PFIZER INC.
$17
Vifor Pharma, Inc.
$15
Insmed, Inc.
$14
INOGEN, INC.
$13
Actelion Pharmaceuticals US, Inc.
$13
Top 3 companies account for 57.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,542
GlaxoSmithKline, LLC.
$1,833
Boehringer Ingelheim Pharmaceuticals, Inc.
$697
United Therapeutics Corporation
$506
Regeneron Healthcare Solutions, Inc.
$482
GENZYME CORPORATION
$420
Mylan Specialty L.P.
$349
Amgen Inc.
$309
Sunovion Pharmaceuticals Inc.
$297
JAZZ PHARMACEUTICALS INC.
$292
Grifols USA, LLC
$262
Merck Sharp & Dohme Corporation
$226
Genentech USA, Inc.
$209
Merck Sharp & Dohme LLC
$202
Amarin Pharma Inc.
$192
Novartis Pharmaceuticals Corporation
$158
COMSORT, Inc
$150
Actelion Pharmaceuticals US, Inc.
$145
Electromed, Inc.
$136
Pulmonx Corporation
$130
Harmony Biosciences LLC
$117
Inspire Medical Systems, Inc.
$112
Terumo Medical Corporation
$104
La Jolla Pharmaceutical Company
$86
CSL Behring
$75
Mallinckrodt Hospital Products Inc.
$72
Outset Medical Inc
$70
SANOFI-AVENTIS U.S. LLC
$69
Mallinckrodt LLC
$63
Allergan Inc.
$57
Jazz Pharmaceuticals Inc.
$55
HARMONY BIOSCIENCES LLC
$53
TETRAPHASE PHARMACEUTICALS, INC.
$45
Takeda Pharmaceuticals U.S.A., Inc.
$45
Philips Electronics North America Corporation
$44
Insmed, Inc.
$43
Philips North America LLC
$41
Avadel CNS Pharmaceuticals, LLC
$40
Bard Peripheral Vascular, Inc.
$39
ABBVIE INC.
$33
Phadia US Inc.
$25
Teva Pharmaceuticals USA, Inc.
$22
Veran Medical Technologies, Inc.
$22
Shire North American Group Inc
$19
Harmony Biosciences Llc
$17
PFIZER INC.
$17
Vifor Pharma, Inc.
$15
PORTOLA PHARMACEUTICALS, INC.
$14
Axsome Therapeutics, Inc.
$14
Circassia Pharmaceuticals Inc
$14
INOGEN, INC.
$13
Top 3 companies account for 46.2% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALLODERM · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · DIFICID · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · FARXIGA · FASENRA · GIAPREZA · GLASSIA · HYQVIA · Hizentra · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ImmunoCAP · Inspire Upper Airway Stimulation System · Kcentra · LONHALA MAGNAIR · LUMRYZ · Misago · NATRELLE · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C · Prolastin-C Liquid · S&RC Und · S&RC Undivided · SMARTVEST · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · UTIBRON · UTIBRON NEOHALER · Utibron · Vascepa · WAKIX · WINREVAIR · Wakix · XOLAIR · XYREM · XYWAV · Xerava · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
8
Per 100K population
3.5
County median income
$55,576
Nearest hospital
HMHP ST ELIZABETH BOARDMAN HEALTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Goldstein is a clinical cardiology specialist, with above-average Medicare volume (top 14% in OH), with low-engagement industry engagement in the top 12% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Goldstein experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Goldstein performed 403 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goldstein receive payments from pharmaceutical companies?
Yes. Dr. Goldstein received a total of $10,991 from 51 companies across 529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goldstein's costs compare to other critical care medicines in Boardman?
Dr. Goldstein's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goldstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Boardman
Browse critical care medicines in Boardman ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in OH
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in OH
Which OH critical care medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology